| Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization M Mohamadzadeh, S Olson, WV Kalina, G Ruthel, GL Demmin, ... Proceedings of the National Academy of Sciences 102 (8), 2880-2885, 2005 | 577 | 2005 |
| Seasonal Pulses of Marburg Virus Circulation in Juvenile Rousettus aegyptiacus Bats Coincide with Periods of Increased Risk of Human Infection BR Amman, SA Carroll, ZD Reed, TK Sealy, S Balinandi, R Swanepoel, ... Public Library of Science 8 (10), e1002877, 2012 | 452 | 2012 |
| Rotavirus antigenaemia and viraemia: a common event? SE Blutt, CD Kirkwood, V Parreño, KL Warfield, M Ciarlet, MK Estes, ... The lancet 362 (9394), 1445-1449, 2003 | 367 | 2003 |
| Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge KL Warfield, DL Swenson, GG Olinger, WV Kalina, MJ Aman, S Bavari The Journal of infectious diseases 196 (Supplement_2), S430-S437, 2007 | 328 | 2007 |
| Ebola virus-like particles protect from lethal Ebola virus infection KL Warfield, CM Bosio, BC Welcher, EM Deal, M Mohamadzadeh, ... Proceedings of the National Academy of Sciences 100 (26), 15889-15894, 2003 | 291 | 2003 |
| Advanced antisense therapies for postexposure protection against lethal filovirus infections TK Warren, KL Warfield, J Wells, DL Swenson, KS Donner, ... Nature medicine 16 (9), 991-994, 2010 | 267 | 2010 |
| Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers KL Warfield, DL Swenson, GG Olinger, DK Nichols, WD Pratt, R Blouch, ... PLoS pathogens 2 (1), e1, 2006 | 194 | 2006 |
| Role of natural killer cells in innate protection against lethal ebola virus infection KL Warfield, JG Perkins, DL Swenson, EM Deal, CM Bosio, MJ Aman, ... The Journal of experimental medicine 200 (2), 169-179, 2004 | 183 | 2004 |
| Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections DL Swenson, D Wang, M Luo, KL Warfield, J Woraratanadharm, ... Clinical and vaccine immunology 15 (3), 460-467, 2008 | 168 | 2008 |
| VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice S Enterlein, KL Warfield, DL Swenson, DA Stein, JL Smith, CS Gamble, ... Antimicrobial agents and chemotherapy 50 (3), 984-993, 2006 | 165 | 2006 |
| Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections DL Swenson, KL Warfield, DL Negley, A Schmaljohn, MJ Aman, S Bavari Vaccine 23 (23), 3033-3042, 2005 | 164 | 2005 |
| Ebola virus uses clathrin-mediated endocytosis as an entry pathway S Bhattacharyya, KL Warfield, G Ruthel, S Bavari, MJ Aman, TJ Hope Virology 401 (1), 18-28, 2010 | 162 | 2010 |
| Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor JH Kuhn, SR Radoshitzky, AC Guth, KL Warfield, W Li, MJ Vincent, ... Journal of Biological Chemistry 281 (23), 15951-15958, 2006 | 156 | 2006 |
| Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection KL Warfield, G Olinger, EM Deal, DL Swenson, M Bailey, DL Negley, ... The Journal of Immunology 175 (2), 1184-1191, 2005 | 154 | 2005 |
| Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein DL Swenson, KL Warfield, K Kuehl, T Larsen, MC Hevey, A Schmaljohn, ... FEMS Immunology & Medical Microbiology 40 (1), 27-31, 2004 | 143 | 2004 |
| Ebola and Marburg virus-like particles activate human myeloid dendritic cells CM Bosio, BD Moore, KL Warfield, G Ruthel, M Mohamadzadeh, ... Virology 326 (2), 280-287, 2004 | 132 | 2004 |
| Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia RP Adhikari, H Karauzum, J Sarwar, L Abaandou, M Mahmoudieh, ... PloS one 7 (6), e38567, 2012 | 125 | 2012 |
| Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viruses KB Spurgers, CM Sharkey, KL Warfield, S Bavari Antiviral research 78 (1), 26-36, 2008 | 123 | 2008 |
| Development and characterization of a mouse model for Marburg hemorrhagic fever KL Warfield, SB Bradfute, J Wells, L Lofts, MT Cooper, DA Alves, DK Reed, ... Journal of virology 83 (13), 6404-6415, 2009 | 121 | 2009 |
| Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection KL Warfield, DL Swenson, DL Negley, AL Schmaljohn, MJ Aman, ... Vaccine 22 (25-26), 3495-3502, 2004 | 111 | 2004 |
